Formulation-dependent [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2017-10-30 11:42 (1974 d 12:26 ago) – Posting: # 17949
Views: 3,003

Hi Anand,

❝ Kindly suggest Discriminatory Dissolution media for Atorvastatin & Rosuvastatin.

That’s not possible. Discriminatory in vitro conditions depend on the properties of formulations. You have to develop ones which are discriminatory for your product.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,555 posts in 4,724 threads, 1,606 registered users;
18 visitors (1 registered, 17 guests [including 9 identified bots]).
Forum time: 01:08 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz